YOLFTbeta
41

Synmosa Biopharma

4114 · TWO · Healthcare / Drug Manufacturers - Specialty & Generic

27.45TWD-0.10 (-0.36%)

Price History

Full chart

Market Stats

Previous Close27.55
Open27.55
Day Range27.25 – 27.60
52-Week Range26.79 – 31.52
Volume1.29M
Market Cap14.96B
P/E (TTM)17.79
Forward P/E33.78
EPS1.65
Dividend Yield2.89%
Beta-0.03
50-Day Avg29.63
200-Day Avg29.38

About

Synmosa Biopharma Corporation, a specialty pharmaceutical company, engages in the manufacturing and sales of various pharmaceuticals and medical devices in Taiwan, China, the United States, Canada, Thailand, Malaysia, Singapore, and internationally. It offers medicines for urology, hormones, oncology, dermatology, cardiovascular, CNS, gastrointestinal, and other areas; and effervescent tables, granules, and nasal sprays. The company is also involved in provision of cosmetics, veterinary drugs, chemical food additives, and beverages; wholesale retail of environmental drugs; and import and export of related businesses. The company was founded in 1959 and is based in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Hong-Qin Bai
  • Employees0
  • HeadquartersNo. 396 Neihu Road, Taipei, Taiwan, 114, Taiwan
  • Websitehttps://www.synmosa.com.tw

Leadership

  • Mr. Hong-Qin BaiSenior VP & Finance Officer
  • Ms. Jia-Xin ZhangSenior Vice President
  • Mr. Sheng-Ren YangSenior Vice President
  • Liyu HuangChief Financial Officer
  • Ching-Hua TsaoAccounting Officer
  • Mr. Zen YoungVice President of Sales - HP, Marketing & Medical

Financials

Income Statement

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.78B1.87B1.86B2.36B2.68B3.04B3.23B4.39B5.14B5.55B6.19B
Growth (%)-+5.00%-0.23%+26.99%+13.40%+13.37%+6.47%+35.59%+17.19%+7.96%+11.53%
Cost of Revenue956.92M1.05B1.14B1.41B1.78B1.91B1.95B2.56B3.02B3.15B3.51B
Gross Profit819.48M814.77M718.25M948.27M895.70M1.13B1.29B1.83B2.12B2.40B2.68B
Gross Margin46.13%43.68%38.60%40.13%33.42%37.29%39.73%41.64%41.24%43.26%43.28%
Operating Expense802.77M865.05M834.11M1.01B1.01B1.01B1.10B1.37B1.50B1.66B1.90B
Operating Income16.72M-50.28M-115.86M-62.00M-116.33M121.51M185.20M455.02M620.34M739.08M777.94M
Operating Margin0.94%-2.70%-6.23%-2.62%-4.34%4.00%5.73%10.37%12.07%13.32%12.57%
EBITDA--14.36M503.23M171.95M852.62M507.92M1.10B1.01B1.06B1.20B
EBITDA Margin--0.77%21.29%6.42%28.06%15.70%25.19%19.62%19.09%19.47%
Net Income31.54M166.65M4.69M430.90M47.09M638.11M303.86M799.09M594.83M684.68M821.85M
Net Income Margin1.78%8.93%0.25%18.23%1.76%21.00%9.39%18.22%11.57%12.34%13.28%
R&D130.83M146.41M187.74M183.74M211.72M159.53M214.37M215.28M210.91M259.72M342.67M
R&D as % of Total Revenue7.36%7.85%10.09%7.77%7.90%5.25%6.63%4.91%4.10%4.68%5.54%
Interest Expense00030.77M54.37M52.82M51.97M59.58M67.26M58.10M62.06M
Interest Expense % of Total Revenue0.00%0.00%0.00%1.30%2.03%1.74%1.61%1.36%1.31%1.05%1.00%

Balance Sheet

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.59B6.79B7.50B7.54B8.73B10.38B10.32B11.20B11.73B12.30B13.99B
Total Liabilities1.58B2.44B3.54B3.06B3.92B4.42B4.22B4.55B3.63B3.91B3.89B
Total Equity2.28B3.04B2.86B3.22B3.48B4.50B4.71B5.31B6.71B7.21B8.76B
Cash231.36M620.16M387.77M447.08M465.10M638.35M868.17M1.09B918.56M1.19B1.89B
Total Debt-----3.70B3.46B3.37B2.44B--
Net Debt--2.16B1.97B2.74B3.06B2.60B2.28B1.52B1.29B565.53M

Cash Flow

Currency: TWD2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow23.60M236.48M-5.19M16.00M-44.88M254.40M444.29M630.25M511.93M780.62M411.57M
Investing Cash Flow-449.31M-1.04B-740.00M-42.03M-598.79M34.50M83.90M-69.33M---
Financing Cash Flow271.96M1.19B520.05M81.66M663.19M-111.78M-297.57M----
Capital Expenditure369.26M423.92M146.93M314.43M183.37M154.41M93.06M129.29M269.77M269.65M281.13M
Free Cash Flow---481.78M-350.16M-247.13M77.20M302.17M445.92M242.16M510.97M130.44M
Dividends Paid24.06M25.53M32.08M35.56M38.02M45.70M79.98M148.63M194.43M228.74M272.61M
FCF to OCF--9275.74%-2189.07%550.61%30.35%68.01%70.75%47.30%65.46%31.69%
Dividend Paid to FCF---6.66%-10.15%-15.38%59.19%26.47%33.33%80.29%44.77%209.00%

Earnings

Report DateJul 15, 2010Oct 29, 2010Apr 28, 2011Aug 30, 2011Mar 30, 2012Aug 30, 2012Nov 14, 2013Mar 31, 2014Aug 14, 2014Nov 13, 2014May 13, 2015Aug 13, 2015Nov 13, 2015Aug 15, 2016Nov 14, 2016Nov 14, 2017Nov 13, 2018May 15, 2019Aug 14, 2019Nov 14, 2019Mar 31, 2020Apr 1, 2020Aug 9, 2020Nov 9, 2020Mar 9, 2021May 12, 2021Aug 16, 2021Nov 9, 2021Mar 29, 2022May 12, 2022Aug 15, 2022Nov 11, 2022Mar 31, 2023May 11, 2023Aug 10, 2023Nov 12, 2023Mar 29, 2024May 15, 2024Nov 12, 2024Mar 28, 2025Apr 29, 2025Aug 13, 2025Nov 14, 2025
EPS Estimate0.090.050.070.07-0.010.060.050.070.130.080.090.030.080.030.05-0.010.160.02--0.170.170.130.100.13-----1.230.270.310.52-0.360.430.360.470.570.480.540.57
EPS Actual0.040.04-0.050.01-0.01-0.070.040.070.080.080.060.020.030.020.010.020.130.04-0.020.050.100.100.940.160.160.190.240.220.290.381.230.250.350.390.500.270.440.340.330.330.270.400.38
Surprise-55.56%-20.00%-171.43%-85.71%0.00%-216.67%-20.00%0.00%-38.46%0.00%-33.33%-33.33%-62.50%-33.33%-80.00%300.00%-18.75%100.00%---41.18%-41.18%623.08%60.00%23.08%-----0.00%-7.41%12.90%-25.00%--25.00%2.97%-5.56%-29.79%-42.11%-43.75%-25.93%-33.33%
TimingAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap14.96B
Enterprise Value15.66B
Trailing P/E17.79
Forward P/E33.78
Price / Sales2.24
Price / Book1.74
EPS1.65
Book Value15.99
Revenue (TTM)6.68B
Gross Profit (TTM)2.75B
EBITDA1.04B
Profit Margin12.38%
Operating Margin11.65%
Return on Equity5.91%
Return on Assets3.05%
Shares Outstanding509.64M
Shares Float413.35M
Beta-0.03
Dividend Yield2.89%
Dividend Rate0.85
Payout Ratio2.23%

Dividends

20261×
0.85Jul 17, 2026
20251×
0.59Jul 11, 2025
20241×
0.53Aug 9, 2024
20231×
0.45Aug 8, 2023
20221×
0.37Jul 11, 2022
20211×
0.20Sep 23, 2021
20201×
0.11Jul 9, 2020
20191×
0.11Jul 11, 2019
20181×
0.10Aug 9, 2018
20171×
0.08Aug 10, 2017
20161×
0.07Aug 9, 2016
20151×
0.07Aug 3, 2015
20141×
0.06Aug 15, 2014
20131×
0.06Aug 12, 2013
20121×
0.03Aug 31, 2012
20111×
0.03Sep 30, 2011
20081×
0.04Dec 11, 2008

Stock Splits

  • Jul 17, 20261079.848:1000
  • Jul 11, 20251099.8486:1000
  • Aug 9, 20241101600:1000000
  • Aug 8, 20231093310.5:1000000
  • Jul 11, 20221101.3506:1000
  • Sep 23, 20211120.898:1000
  • Jul 9, 20201073.605:1000
  • Jul 11, 20191139.276:1000
  • Aug 9, 20181099.979:1000
  • Aug 10, 20171120:1000
  • Aug 9, 20161086.454:1000
  • Aug 3, 20151080.176:1000
  • Aug 15, 20141076.073:1000
  • Aug 12, 20131.0608:1
  • Aug 31, 20121.05:1
  • Sep 30, 20111.0527:1
  • Sep 25, 2009106.801:100
  • Dec 11, 2008106:100